Industry Perspectives on Preparing Validation-Ready NGS Workflows
Alison Waterfield May 17, 2026
Driving Biopharma Automation and AI
Unlocking NGS and Regulatory Synergy in GCT for Maximum Impact
NGS for Product Characterization in CGT: Biosafety and Genome Integrity
From Science to Compliance: Effective Validation of Genedata Selector
Genedata for developability across biopharma R&D
Discover What’s New in Genedata Screener 2026
Genedata Biopharma Platform: Compliance-Ready
Lessons Learned from a Full-Scale GMP Validation of NGS Workflows
Next Era of Bioprocessing: Driving Innovation through Digital CMC and AI
Unified Platform for Assay Development and GMP‑Ready NGS Analytics In-House
NGS‑MAM Framework for Comprehensive Vector Characterization
Automated NGS Data Analysis in AAV Upstream Manufacturing
Japan: Cutting Days from the DMTA Cycle in Discovery Research
NGS Made Practical: Meeting European Pharmacopoeia Standards
March 30, 2026
Integration Genedata Bioprocess Äkta UNICORN
Genedata Flexible Deployment for Any Digital Ecosystem.
AI-ready Bioprocess Unified Data Foundation
Genedata Selector Product Development Roadmap
Genedata’s Unparalleled Partner Symposium, 2026 Edition
March 12, 2026
Merck Automates MS-Based Workflows to Accelerate ADC Discovery
Automating LC-Based N-Glycan Analysis for CMC
Automated Assay Analytics from Discovery to CMC
Deriving an RNA Quality Scoring Method Applicable to a broad Range of Instruments
Novartis Accelerates IND Timelines by Digitalizing CMC Processes
Data in Motion. Accelerated CMC Decisions.
Genedata Vico
Digital Transformation in Biopharma Data Management
Raed Hmadi March 2, 2026
Japan: Driving Next-Generation Discovery with Organoids
In-and-Out Characterization and CQA Monitoring of AAVs
Automation in Biopharma: Cell Line & Process Development
Raed Hmadi February 26, 2026
Japan: Increasing Efficiency of Antibody Discovery and Engineering Workflows
Streamlining CGT Data for TCR Engineering
Raed Hmadi February 25, 2026
Boehringer Ingelheim Accelerates NGS-Driven Cell Line Characterization
The Real Benefits (and Remaining Barriers) to AI in Biopharma
Mark Brewer, PhD, Ada Yee, PhD February 19, 2026
From Screening to Sequencing: Digital Backbone for Antibody Discovery
Japan: Utilizing Genedata Biologics’ Versatility for Cloud Software Integrations
Therapeutic Antibody Profiling with Genedata Biologics — AI & ML Framework for Cancer Drug Discovery
Predict Drug Efficacy. Improve Clinical Trial Success.
Genedata Profiler
Accelerating CMC with NGS through AI-Driven and GMP-Compliant Digital Infrastructure
NGS Data Analysis Automation for R&D & QC
Raed Hmadi February 6, 2026
